Physician

Karen Imma C Gellada, MD

According to 2025 Medicare claims, Karen Gellada, MD (NPI: 1285897967) practices undersea and hyperbaric medicine in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is ADVOCATE HEALTH AND HOSPITALS CORPORATION (NPI: 1700824455; TIN: 362169147) and primary practice location at 60010-1919. Gellada is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), Mercy Health Corporation (ACO ID: A2097), and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Gellada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 189 traditional Medicare patients, billed 502 HCPCS/CPT codes, and received $28,754 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,232 prescription claims across 304 beneficiaries totaling $440,040 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $39,565 and ending at $28,754. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $196,522 to $440,040. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $7,206 and ending at $15,612.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	170	738	$39,565
2016	N/R	N/R	N/R
2017	139	557	$30,205
2018	188	976	$48,664
2019	175	898	$42,513
2020	211	559	$31,113
2021	231	694	$49,353
2022	210	710	$48,490
2023	181	616	$42,394
2024	189	502	$28,754

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	227	4,011	$196,522
2016	121	465	$25,352
2017	128	735	$26,927
2018	158	1,859	$88,457
2019	172	2,246	$107,810
2020	294	2,719	$161,750
2021	341	5,544	$397,733
2022	324	5,145	$400,795
2023	314	5,089	$502,923
2024	304	4,232	$440,040

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	117	$4,848
2016	N/R	N/R	N/R
2017	N/R	23	$592
2018	N/R	54	$1,711
2019	N/R	67	$3,858
2020	N/R	48	$1,193
2021	13	77	$2,725
2022	N/R	39	$315
2023	N/R	76	$4,924
2024	N/R	11	$170

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	56	56	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	90	125	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	90	167	$48
97597	Removal of tissue from wound, 20.0 sq cm or less	16	30	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	24	25	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	63	3,097	$59,433
Farxiga	Dapagliflozin Propanediol	60	3,094	$53,419
Mounjaro	Tirzepatide	35	1,316	$46,919
Jardiance	Empagliflozin	28	1,968	$37,943
Ozempic	Semaglutide	18	616	$18,873

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$170

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Karen Imma C. Gellada, MD?

Tedicare shows public-source Medicare data for Karen Imma C. Gellada, MD (NPI 1285897967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karen Imma C. Gellada, MD have ACO affiliation data?

Karen Imma C. Gellada, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033), Mercy Health Corporation (MSSP, ACO ID A2097), and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Karen Imma C. Gellada, MD?

Karen Imma C. Gellada, MD is linked to ADVOCATE HEALTH AND HOSPITALS CORPORATION (billing NPI 1700824455) in the available physician profile data.

Does Karen Imma C. Gellada, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.